Transport Characteristics of 6-Mercaptopurine in Brain Microvascular Endothelial Cells Derived From Human Induced Pluripotent Stem Cells
- 1 October 2021
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 110 (10) , 3484-3490
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science (19K07231)
- Institut National de la Santé et de la Recherche Médicale (19K07231)
This publication has 31 references indexed in Scilit:
- Characterization of 6-Mercaptopurine Transport by the SLC43A3-Encoded Nucleobase TransporterMolecular Pharmacology, 2019
- Functional identification of SLC43A3 as an equilibrative nucleobase transporter involved in purine salvage in mammalsScientific Reports, 2015
- Acute lymphoblastic leukaemiaThe Lancet, 2013
- Incidence and survival rates of hematological malignancies in Japanese children and adolescents (2006–2010): based on registry data from the Japanese Society of Pediatric HematologyInternational Journal of Hematology, 2013
- Organic anion transporter 3 is involved in the brain‐to‐blood efflux transport of thiopurine nucleobase analogsJournal of Neurochemistry, 2004
- Thiopurine Metabolism and Identification of the Thiopurine Metabolites Transported by MRP4 and MRP5 Overexpressed in Human Embryonic Kidney CellsMolecular Pharmacology, 2002
- Plasma pharmacokinetics and cerebrospinal fluid penetration of thioguanine in children with acute lymphoblastic leukemia: a collaborative Pediatric Oncology Branch, NCI, and Children's Cancer Group studyCancer Chemotherapy and Pharmacology, 2001
- Brain distribution of 6-mercaptopurine is regulated by the efflux transport system in the blood-brain barrier 1Life Sciences, 2000
- Pharmacokinetics and distribution of 6-mercaptopurine administered intravenously in children with lymphoblastic leukaemiaEuropean Journal of Clinical Pharmacology, 1997
- Prevention and treatment of meningeal leukemia in childrenBlood, 1994